Drug Accelerated Growth in Children With Dwarfism, Pharmaceutical Firm Says

BioMarin Pharmaceutical says that in its preliminary study, 10 children with achondroplasia who got the highest doses of vosoritide grew at an average rate of 2.4 inches a year.